What is the dosage of platinib for patients with lung cancer?

Platinib, as a targeted anti-cancer drug targeting specific genetic mutations, provides a new treatment option for lung cancer patients, especially those with non-small cell lung cancer carrying transfection rearrangement (RET) gene fusion-positive patients. However, for many patients, how to use platinib correctly and rationally to achieve the best therapeutic effect is still a matter of concern. This article will introduce in detail the usage and dosage of Platinib in patients with lung cancer to help patients better understand and follow medical instructions.

Platinib is mainly taken orally and is presented in capsule form. For adult patients, the recommended dose is 400 mg once daily. To ensure adequate absorption and optimal efficacy of the drug, patients should take Platinib on an empty stomach, meaning they should avoid eating for at least 2 hours before taking the drug and for at least 1 hour after taking the drug. This medication requirement helps reduce the impact of food on drug absorption and ensures that the drug reaches an effective concentration in the body.

While taking platinib, patients should pay attention to the following points:

1. Take medication at a fixed time: It is recommended to take medication at the same time every day to maintain a stable blood concentration and ensure the therapeutic effect.

2. Avoid missing doses: If you miss a dose, you should take it as soon as possible on the same day and continue taking the medication at the normal time the next day. However, if it is already time for your next dose, there is no need to take the missed dose to avoid overdose.

3. Note on adverse reactions: Although Platinib is generally well tolerated, some patients may experience adverse reactions such as fatigue, diarrhea, and hypertension. Once discomfort occurs, you should contact your doctor immediately so that the treatment plan can be adjusted in a timely manner.

4. Follow medical advice: The most important thing is that patients should strictly follow the doctor’s instructions and are not allowed to increase or decrease the dosage or change the frequency of medication on their own. The doctor will adjust the treatment plan according to the patient's specific situation and changes in condition.

In addition, patients who are taking other medications should inform their doctors of all medications they are taking, especially those that may affect the efficacy of Platinib or increase side effects. Doctors will evaluate the interactions between drugs based on the patient's specific situation and give corresponding medication recommendations.

In short, lung cancer patients should strictly follow the doctor's instructions when using platinib, take the medicine on time and in the right amount, and pay close attention to their own reactions. With correct usage and dosage and a reasonable treatment plan, patients are expected to obtain better treatment effects and quality of life.